By viewing this on-demand webinar you will come away with a greater understanding of:
- The potential mechanisms underlying cardiac biomarkers elevation with COVID-19 infections
- What biomarkers should be tested and when for the diagnosis of cardiovascular conditions in COVID-19 patients
- Value of cardiac biomarkers in COVID-19 patient management
Professor James L. Januzzi Jr, MD, FACC, FESC
Hutter Family Professor of Medicine, Harvard Medical School;
Physician, Cardiology Division, Massachusetts General Hospital;
Cardiometabolic Faculty, Baim Institute for Clinical Research;
Trustee, American College of Cardiology;
Tijana Krnjeta Janicijevic, PharmD PhD
Tijana Krnjeta Janicijevic is a Senior International Medical Affairs Manager in Roche Diagnostics International.
Tijana holds PhD in pharmacy from Faculty of Pharmacy, University of Belgrade.
She has been working for Roche Diagnostics since 2009, and went through various roles with increasing responsibilities and expertise’s. Currently Tijana is responsible for global medical strategy for biomarkers in heart failure management, leading global medical education activities as well as further clinical evidence generation.